AEOL-10113

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAEOL-10113
Drug Alias NameAEOL-10113AEOL-10123AEOL-10112
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsNeuroprotectantsFree radicals scavengers +[4] 
TargetsFree radicals
Therapy Area/IndicationsLung MalformationDiabetes Mellitus, Type 1Reperfusion Injury +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAeolus Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAeolus Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsLung MalformationDiabetes Mellitus, Type 1Reperfusion Injury +[7] 

Other Information

ATC CodeN/A
Related LinksN/A